Molecular Partners AG (SWX:MOLN)

Switzerland · Delayed Price · Currency is CHF

3.050

-0.070 (-2.24%)

Apr 1, 2026, 5:30 PM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharmaceutical Products		4.97M	7.04M	189.60M	9.75M	9.34M
Biopharmaceutical Products Growth		-29.38%	-96.29%	1843.82%	4.39%	-54.16%
Total		4.97M	7.04M	189.60M	9.75M	9.34M
Total Growth		-29.38%	-96.29%	1843.82%	4.39%	-54.16%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Switzerland		4.97M	7.04M	179.90M	-	-
Switzerland Growth		-29.38%	-96.09%	-	-	-
USA		-	-	9.65M	9.33M	9.34M
USA Growth		-	-	3.46%	-0.15%	-54.16%
Total		4.97M	7.04M	189.56M	9.33M	9.34M
Total Growth		-29.38%	-96.29%	1931.68%	-0.15%	-54.16%

Source: S&P Global Market Intelligence.